Ssu-Hsueh Tseng

Johns Hopkins University — United States

Immunology and Microbiology · Life Sciences

10h-index308citations12works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(4), Immune Cell Function and Interaction(3), Cervical Cancer and HPV Research(2), Cancer Immunotherapy and Biomarkers(2), Ubiquitin and proteasome pathways(2)

Publications12 total

Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer
PLoS ONE·2024· 1 citedOpen Access
Protein detection in blood with single-molecule imaging
Science Advances·2021· 37 citedOpen Access
Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract
Cancer Research·2021· 20 citedOpen Access
A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions
Journal of Biomedical Science·2021· 46 citedOpen Access
NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells
Cancer Immunology Immunotherapy·2020· 13 citedOpen Access
Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis
Journal for ImmunoTherapy of Cancer·2020· 7 citedOpen Access
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties
PLoS ONE·2020· 12 citedOpen Access
TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy
Journal for ImmunoTherapy of Cancer·2019· 49 citedOpen Access
Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16+ Oral Tumors and Immunologic Control
Cancer Immunology Research·2018· 20 citedOpen Access
Bioinformatics and <i>in vitro</i> experimental analyses identify the selective therapeutic potential of interferon gamma and apigenin against cervical squamous cell carcinoma and adenocarcinoma
Oncotarget·2017· 36 citedOpen Access
RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells
Oncotarget·2016· 29 citedOpen Access
Up-regulation of <i>miR-187</i> modulates the advances of oral carcinoma by targeting <i>BARX2</i> tumor suppressor
Oncotarget·2016· 38 citedOpen Access

Frequent Co-authors

Chien‐Fu Hung(10), Brandon Lam(5), Richard B.S. Roden(5), Emily Farmer(4), Andrew Yang(3), T.‐C. Wu(3), Ravi Anchoori(3), Chih‐Ping Mao(2), Yu Jui Kung(2), John Lin(2), Louise Ferrall(2), Liangmei He(2), Ruey-Shyang Soong(2), Ya-Chea Tsai(2), Shiwen Peng(2), Talia R. Henkle(2), Deyin Xing(2), Max A. Cheng(2), Tae Heung Kang(1), Young Seob Kim(1)